Institut Pasteur is a private, non-profit foundation with recognized charitable status, for biomedical research, established in 1887 by Louis Pasteur and hosting about 3000 staff members and 142 research structures. The Institut Pasteur is committed to conducting outstanding research to improve global health. Its missions are to help prevent and treat diseases, mainly those of infectious origin, through research, public health, education and training, and the development of research applications. The Institut Pasteur is also at the centre of a unique international network, the Pasteur Network, a human and scientific community with 33 members in over 20 countries across all five continents working together to help achieve its missions.
Internationally recognized as a leader in infectious diseases, microbiology, and immunology, the Institut Pasteur conducts cutting-edge research focused on understanding the biology of living systems. Since its founding, ten of its scientists have been awarded the Nobel Prize in Medicine, including two in 2008 for the groundbreaking discovery of the human immunodeficiency virus (HIV) in 1983—the virus that causes AIDS.
In response to growing global health challenges—including infectious diseases, antimicrobial resistance, aging, climate change, chronic inflammatory conditions, cancers (increasingly affecting younger populations), and neurodegenerative disorders—the Institut Pasteur is committed to strengthening its position as the world’s leading research organization in understanding and combating these threats by 2030.
Within the Flavivaccine consortium, Institut Pasteur provides critical expertise on innovative pre-clinical animal models in order to assess vaccine prototypes for protection against flavivirus infection.